BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/21/2025 6:10:15 AM | Browse: 26 | Download: 36
 |
Received |
|
2024-12-25 10:48 |
 |
Peer-Review Started |
|
2024-12-27 01:11 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-01-16 13:13 |
 |
Revised |
|
2025-01-21 01:58 |
 |
Second Decision |
|
2025-02-18 02:37 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-02-18 08:30 |
 |
Articles in Press |
|
2025-02-18 08:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2025-02-22 01:39 |
 |
Typeset the Manuscript |
|
2025-03-13 08:51 |
 |
Publish the Manuscript Online |
|
2025-03-21 06:10 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell Biology |
Manuscript Type |
Letter to the Editor |
Article Title |
Efficacy equivalence but hidden hurdles: Can serum-free human umbilical cord mesenchymal stem cells translate to clinically superior osteoarthritis therapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Fang Lin, Ke-Xin Ma, Yue Ding and Xiao-Ting Liang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Foundation of Shanghai |
24ZR1459300 |
Pyramid Talent Project |
YQ677 |
|
Corresponding Author |
Xiao-Ting Liang, Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, No. 150 Jimo Road, Shanghai 200120, China. liangxt@tongji.edu.cn |
Key Words |
Mesenchymal stem cells; Serum-free culture; Osteoarthritis; Cartilage repair; Regenerative medicine |
Core Tip |
This article evaluates the study by Xiao et al on using serum-free cultured human umbilical cord mesenchymal stem cells (N-hUCMSCs) to treat knee osteoarthritis in a mouse model. Although N-hUCMSCs matched the efficacy of both serum-cultured hUCMSCs and hyaluronic acid, future research must clarify how N-hUCMSCs differ in long-term proliferative capacity and senescence profiles compared to their serum-cultured counterparts. Additionally, since hyaluronic acid is an established osteoarthritis treatment, demonstrating clear advantages, such as fewer side effects, more durable outcomes, or enhanced cartilage regeneration, will be crucial for justifying the clinical adoption of N-hUCMSCs. |
Publish Date |
2025-03-21 06:10 |
Citation |
<p>Lin F, Ma KX, Ding Y, Liang XT. Efficacy equivalence but hidden hurdles: Can serum-free human umbilical cord mesenchymal stem cells translate to clinically superior osteoarthritis therapy. <i>World J Stem Cells</i> 2025; 17(3): 104566</p> |
URL |
https://www.wjgnet.com/1948-0210/full/v17/i3/104566.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v17.i3.104566 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345